Maternal immunization against viral disease

Vaccine

Volumn 16, Issue 14-15, 1998, Pages 1456-1463

  Englund, Janet ^a   Glezen, W Paul ^a   Piedra, Pedro A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Influenza vaccine; Maternal immunization; Poliovaccine; Purified fusion protein vaccine of RSV; Respiratory syncytial virus; Vaccines

Indexed keywords

HERPES VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; MATERNAL ANTIBODY; PFP 1; PFP 2; POLIOMYELITIS VACCINE; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RUBELLA VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; VIRUS VACCINE;

BREAST MILK; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; FEMALE; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; INFLUENZA VIRUS; MATERNAL CARE; PARAINFLUENZA VIRUS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PUERPERIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RUBELLA VIRUS; VIRUS INFECTION;

FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; PREGNANCY; VIRAL VACCINES; VIRUS DISEASES;

EID: 0032147233     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00108-X     Document Type: Conference Paper

References (75)

1. 1 Glezen, W.P., Parades, A., Allison, J.E., Taber, L.H. and Frank, A.L. Risk of respiratory syncytial virus infection for infants from low-income families in relation to age, sex, ethnic group, and maternal antibody level. Journal of Pediatrics 1981, 98, 708-715.
2. 2 Puck, J.M., Glezen, W.P., Frank, A.L. and Six, H.R. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. Journal of Infectious Diseases 1980, 142, 844-849.
3. 3 Reuman, P.D., Ayoub, E.M. and Small, P.A. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. Pediatrics and Infectious Diseases Journal 1987, 6, 398-403.
4. 4 Linder, N. and Ohel, G. In utero vaccination. Clinics in Perinatology 1994, 21, 663-674.
5. 5 Gershon, A., Raker, R., Steinberg, S., Toph-Olstein, B. and Drusin, L.M. Antibody to Varicella-Zoster virus in parturient women and their offspring during the first year of life. Pediatrics 1976, 58, 692-696.
6. 6 Prober, C.G., Sullender, W.M., Yasukawa, L.L., Au, D.S., Yeager, A.S. and Arvin, A.M. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. New England Journal of Medicine 1987, 316, 240-244.
7. 7 Demmler, G. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Reviews in Infectious Diseases 1991, 13, 315-329.
8. 8 Englund, J.A. and Glezen, W.P. Maternal immunization for the prevention of infection in early infancy. Seminars in Pediatric Infectious Diseases 1991, 2, 225-231.
9. 9 Englund, J.A., Mbawuike, I., Hammill, H., Holleman, M.C., Baxter, B.D. and Glezen, W.P. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. Journal of Infectious Diseases 1993, 168, 647-656.
10. 10 Gill, T.J., Repetti, C.F. and Metlay, L.A. et al. Transplacental immunization of the human fetus to tetanus by immunization of the mother (Abstr). Clinical Investigation 1983, 72, 987-996.
11. 11 Centers for Disease Control, Advisory Committee on Immunization Practices. MMWR: Prevention and Control of Influenza, 1997,RR-9:1-25, (Abstr.).
12. 12 Heinonen, O.P., Shapiro, S., Monson, R.R., Hartz, S.C., Rosenberg, L. and Sloane, D. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. International Journal of Epidemiology 1973, 2, 229-235.
13. 13 Harjulehto-Mervaala, T., Aro, T., Hiilesmaa, V.K., Saxen, H., Hovi, T. and Saxen, L. Oral polio vaccination during pregnancy: no increase in the occurrence of congenital malformations. American Journal of Epidemiology 1993, 138, 407-414.
14. 14 Ornoy, A. and Ishai, P.B. Congenital anomalies after oral poliovirus vaccination during pregnancy. Lancet 1993, 341, 1162
15. 15 Linder, N., Handsher, R. and Fruman, O. et al. Effect of maternal immunization with oral poliovirus vaccine on neonatal immunity. Pediatric Infectious Diseases Journal 1994, 13, 959-962.
16. 16 Tsai, T.F., Paul, R., Lynberg, M.C. and Letson, G.W. Congenital yellow fever virus infection after immunization in pregnancy. Journal of Infectious Diseases 1993, 168, 1520-1523.
17. 17 Mohle-Boetani, J.C., Schuhat, A., Plikaytis, B.D., Smith, J.D. and Broome, C.V. Comparison of prevention strategies for neonatal group B streptococcal infection: a population-based economic analysis. JAMA 1993, 270, 1442-1448.
18. 18 Englund, J.A., Glezen, W.P., Turner, C., Harvey, J., Thompson, C. and Siber, G.R. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenza Type b vaccines. Journal of Infectious Diseases 1995, 171, 99-105.
19. 19 deSierra, T.M., Kumar, M.L., Wasser, T.E., Murphy, B.R. and Subbarao, E.K. Respiratory syncytial virus-specific immunoglobulins in preterm infants. Journal of Pediatrics 1993, 122, 787-791.
20. 20 Baker, C.J. Immunization to prevent group B streptococcal disease: victories and vexations. Journal of Infectious Diseases 1990, 161, 917-921.
21. 21 Heinonen, O.P., Slone, D. and Shapiro, S., Immunizing agents. In Birth Defects and Drugs in Pregnancy, ed. D.W. Kaufman. Publishing Sciences Group, Littleton, MA, 1977, pp. 314-321.
22. 22 Siegel, M. and Greenberg, M. Poliomyelitis in pregnancy: effect on fetus and newborn infant. Journal of Pediatrics 1956, 49, 280-288.
23. 23 DaSilva, M.M., Prem, K.A. and Johnson, E.A. et al. Response of pregnant women and their infants to poliomyelitis vaccine. Distribution of poliovirus antibody in pregnant women before and after vaccination. Transfer, persistence and induction of antibodies in infants. JAMA 1958, 168, 1-5.
24. 24 Hortsmann, D.M., Opton, E.M. and Klemperer, R. et al. Vieremia in infants vaccinated with oral poliovirus vaccine (Sabin). American Journal of Hygiene 1964, 79, 47-63.
25. 25 Harjulehto-Mervaala, T., Aro, T., Hiilesmaa, V.K., Hovi, T., Saxen, H. and Saxen, L. Oral polio vaccination during pregnancy: lack of impact on fetal development and perinatal outcome. Clinical Infectious Diseases 1994, 18, 414-420.
26. 26 Centers for Disease Control. Rubella vaccination during pregnancy - United States. 1971-1988. MMWR, 1989, 38, 289-293.
27. 27 Glezen, W.P. and Couch, R.B. Influenza virus. In Viral Infections in Humans, eds A.S. Evans and R.A. Kaslow. Plenum Press, New York, 1997, pp. 473-505.
28. 28 Eickhoff, T.C., Sherman, I.L. and Serfling, R.E. Observations on excess mortality associated with epidemic influenza. JAMA 1961, 176, 776-782.
29. 29 Serfling, R.E., Sherman, L.L. and Houseworth, W.J. Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957-58, 1960, and 1963. American Journal of Epidemiology 1967, 86, 443-449.
30. 30 Shahab, S.Z. and Glezen, W.P., Influenza virus. In Viral Diseases in Pregnancy, ed. B. Gonik. Springer-Verlag, New York, 1994, pp. 215-223.
31. 31 Mbawuike. I., Six, H.R., Cate, T.R. and Couch, R.B. Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes. Journal of Virology 1990, 64, 1370-1374.
32. 32 Griffiths, P.D., Ronalds, C.J. and Heath, R.B. A prospective study of influenza infections during pregnancy. Journal of Epidemiology and Community Health 1980, 34, 124-128.
33. 33 Murray, D.L., Imagawa, D.T., Okada, D.M. and St Geme, J.W. Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women. Journal of Clinical Microbiology 1979, 10, 184-187.
34. 34 Sumaya, C.V. and Gibbs, R.S. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. Journal of Infectious Diseases 1979, 140, 141-146.
35. 35 Denny, F.W. Acute respiratory infection in children: etiology and epidemiology. Pediatric Review 1987, 9, 135-146.
36. 36 Avendano, L.F., Larranga, C. and Palomino, M.A. et al. Community and hospital-acquired respiratory syncytial virus infections in Chile. Pediatric Infectious Diseases Journal 1991, 10, 564-568.
37. 37 Brussow, H., Werchau, H. and Sidoti, J. et al. Age related prevalence of serum antibody to respiratory syncytial virus in Ecuadorian and German children. Journal of Infectious Diseases 1991, 163, 679-680.
38. 38 Dagan, R., Landau, D., Haikin, H. and Tal, A. Hospitalization of Jewish and Bedouin infants in Southern Israel for bronchiolitis caused by respiratory syncytial virus. Pediatric Infectious Diseases Journal 1993, 12, 381-386.
39. 39 Dym, A.M., Schuit, K.E., Nwankwo, M.U. and Omene, J.A. Respiratory syncytial virus and acute lower respiratory infections in Bennin City, Nigeria. Pediatric Infectious Diseases Journal 1986, 5, 717-718.
40. 40 Forgie, I.M., Campbell, H. and Lloyd-Evans, N. et al. Etiology of acute lower respiratory tract infections in children in a rural community in The Gambia. Pediatric Infectious Diseases Journal 1992, 11, 466-473.
41. 41 Sunakorn, P., Chunchit, L., Niltawat, S., Wangweerawong, M. and Jacobs, R.F. Epidemiology of acute respiratory infections in young children from Thailand. Pediatric Infectious Diseases Journal 1990, 9, 873-877.
42. 42 Glezen, W.P., Loda, F.A. and Clyde, W.A. et al. Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. Journal of Pediatrics 1971, 78, 397-406.
43. 43 Glezen, W.P., Taber, L.H. and Frank, A.L. et al. Risk of primary infection and reinfection with respiratory syncytial virus. American Journal of Diseases in Children 1986, 140, 543-546.
44. 44 Glezen, W.P. Pathogenesis of bronchiolitis: epidemiologic considerations. Pediatric Research 1977, 11, 239-243.
45. 45 Hall, C.B., Kopleman, A.E., Douglas, R.G. Jr.Jr., Geiman, J.M. and Meagher, M.P. Neonatal respiratory syncytial virus infection. New England Journal of Medicine 1979, 300, 393-396.
46. 46 MacDonald, N.E., Hall, C.B., Suffin, S.C., Alexson, C., Harris. P.J. and Manning, J.A. Respiratory syncytial viral infection in infants with congenital heart disease. New England Journal of Medicine 1982, 307, 397-400.
47. 47 Hall, C.B., Powell, K.R. and MacDonald, N.E. et al. Respiratory syncytial viral infection in children with compromised immune function. New England Journal of Medicine 1986, 315, 77-81.
48. 48 Englund, J.A. Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody. Pediatric Infectious Diseases Journal 1994, 13, 449-453.
49. 49 Walsh, E.E. Respiratory syncytial virus infection: are strain differences important?. Pediatric Virology 1989, 4, 1-5.
50. 50 Hall, C.B., Walsh, E.E., Long, C.E. and Schnabel, K.C. Immunity to and frequency of reinfection with respiratory syncytial virus. Journal of Infectious Diseases 1991, 163, 693-698.
51. 51 Wagner, D.K., Muelenaer, P. and Henderson, F.W. et al. Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections. Journal of Clinical Microbiology 1989, 27, 589-592.
52. 52 Welliver, R.C., Sun, M., Hildreth, S.W., Arumugham, R. and Ogra, P.L. Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotopes to the F and G proteins and to intact virus after natural infection. Journal of Clinical Microbiology 1989, 27, 295-299.
53. 53 McConnochie, K.M., Hall, C.B., Walsh, E.E. and Roghmann, K.J. Variation in severity of respiratory syncytial virus infections with subtype. Journal of Pediatrics 1990, 117, 52-62.
54. 54 Hall, C.B., Walsh, E.E. and Schnabel, K.C. et al. Occurrence of groups A and B respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. Journal of Infectious Diseases 1990, 162, 1283-1290.
55. 55 Kapikian, A.Z., Mitchell, R.H., Chanock, R.M., Shvedoff, R.A. and Stewart, C.E. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. American Journal of Epidemiology 1969, 89, 405-421.
56. 56 Kim, H.W., Canchola, J.G. and Brandt, C.D. et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 1969, 89, 422-434.
57. 57 Prince, G.A., Hemming, V.G. and Horswood, R.L et al. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Research 1985, 3, 193-206.
58. 58 Walsh, E.E., Hall, C.B., Briselli, M., Brandriss, M.W. and Schlesinger, J.J. Protection from respiratory syncytial viral infection in cotton rats by viral glycoprotein subunit immunization. Journal of Infectious Diseases 1987, 55, 1198-1204.
59. 59 Bruhn, F.W. and Yeager, A.S. Respiratory syncytial virus in early infancy: circulating antibody and the severity of infection. American Journal of Diseases in Children 1977, 131, 148-152.
60. 60 Ogilvie, M.M., Vathenen, A.S., Radford, M., Codd, J. and Key, S. Maternal antibody and respiratory syncytial virus infection in infancy. Journal of Medicine and Virology 1981, 17, 263-271.
61. 61 Ward, K.A., Lambden, P.R., Ogilvie, M.M. and Watt, P.J. Antibodies to respiratory syncytial virus polypeptides and their significance in human infection. Journal of General Virology 1983, 64, 1867-1876.
62. 62 Kasel, J.A., Walsh, E.E., Frank, A.L., Baxter, B.D., Taber, L.H. and Glezen, W.P. Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children. Viral Immunology 1987, 1, 199-205.
63. 63 Meurman, O., Waris, M. and Hedman, K. Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection. Journal of Clinical Microbiology 1992, 30, 1479-1484.
64. 64 Tristram, D.A., Welliver, R.C., Mohar, C.K., Hogerman, D.A., Hildreth, S.W. and Paradiso, P.R. Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old. Journal of Infectious Diseases 1993, 167, 191-195.
65. 65 Belshe, R.B., Anderson, E.L. and Walsh, E.E. Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children. Journal of Infectious Diseases 1993, 168, 1024-1029.
66. 66 Piedra, P.A., Glezen, W.P. and Kasel, J.A. Safety and immunogenicity of the PFP vaccine against RSV: the Western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection. Vaccine 1995, 13, 1095.
67. 67 Piedra, P.A., Grace, S. and Jewell, A. et al. Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. Pediatric Infectious Diseases Journal 1996, 15, 23-31.
68. 68 Groothuis, J.R., Simoes, E.A.F. and Levin, J.J. et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. New England Journal of Medicine 1994, 329, 1524-1530.
69. 69 Suffin, S.C., Prince, G.A., Muck, K.B. and Porter, D.D. Immunoprophylaxis of respiratory syncytial virus infection in the infant ferret. Journal of Immunology 1979, 123, 10-14.
70. 70 Buraphacheep, W. and Sullender, W.M. The guinea pig as a model for the study of maternal immunization against respiratory syncytial virus infection in infancy. Journal of Infectious Diseases 1997, 175, 935-938.
71. 71 Brandt, C.D., Ultan, F.P. and Plotnicky-Gilquin, H. et al. Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na. Journal of Infectious Diseases 1997, 176, 884-891.
72. 72 Crowe, J., Phuong, T.B. and Firestone, C.Y. et al. Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates. Journal of Infectious Diseases 1996, 173, 829-839.
73. 73 Siber, G.R., Leszczynski, J. and Pena-Cruz, V. et al. Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. Journal of Infectious Diseases 1992, 165, 456
74. 74 Koen, K., Van Rompay, A. and Otsyula, M.G. et al. Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection. Journal of Infectious Diseases 1996, 173, 1327-1335.
75. 75 Lambert, J.S., Mofeson, L.M. and Fletcher, C.V. et al. Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Journal of Infectious Diseases 1997, 175, 283-290.